Vascular News and Research

RSS

Leica Microsystems launches new neurosurgical microscope

Leica Microsystems has launched a new neurosurgical microscope, the Leica M530 OH6. To enable surgeons to see better into deep, narrow cavities, it is equipped with FusionOptics technology, advanced Small Angle Illumination (SAI) and apochromatic optics. The ergonomic design of the microscope enables surgeons and assistants to work in a neutral, upright posture which helps prevent strain and fatigue.

From Leica Microsystems GmbH 14 Oct 2014

New miniaturized, wireless monitoring system for heart failure patients

A new miniaturized, wireless monitoring system, implanted in the pulmonary artery, is helping keep patients with severe heart failure out of the hospital. Houston Methodist Hospital is the first institution in Houston to offer this to heart failure patients.

14 Oct 2014

Multi-center study compares clinical performance of AAA procedures in virtual environment

University Hospitals (UH) Case Medical Center and Simbionix recently launched a multi-center, randomized study comparing the clinical performance of abdominal aortic aneurysm (AAA) procedures with and without prior rehearsal in a virtual environment for physicians.

13 Oct 2014

New surface coating for medical devices prevents blood from clotting

From joint replacements to cardiac implants and dialysis machines, medical devices enhance or save lives on a daily basis. However, any device implanted in the body or in contact with flowing blood faces two critical challenges that can threaten the life of the patient the device is meant to help: blood clotting and bacterial infection.

13 Oct 2014

BHVH cardiologists implant investigational cardiac pacemaker the size of multivitamin

Cardiologists on the medical staff at Baylor Jack and Jane Hamilton Heart and Vascular Hospital (BHVH) today implanted an investigational cardiac pacemaker the size of a multivitamin.

From Medtronic 9 Oct 2014

Neovasc gets conditional IDE approval from FDA to initiate trial for Tiara mitral valve system

Neovasc Inc. today announced that it has received conditional Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration to initiate the U.S. arm of its TIARA-I Early Feasibility Trial for the Company's Tiara™ transcatheter mitral valve.

9 Oct 2014

MedCure offers Pulsatile Anatomical Trainer service to advance medical research and training

After three years in development, MedCure, Inc. has perfected a technique that mimics functioning circulatory system processes in cadaveric specimens.

8 Oct 2014

Health Canada approves Lucentis (ranibizumab) for myopic CNV

Novartis Pharmaceuticals Canada Inc. announced today that Lucentis (ranibizumab), the treatment for several major causes of vision loss, has been approved by Health Canada for the treatment of visual impairment due to choroidal neovascularization (CNV) secondary to pathologic myopia (myopic CNV).

8 Oct 2014

CTRC researcher receives special $1.62 million orphan disease grant from FDA

A researcher at the Cancer Therapy & Research Center is the leader on a study receiving a special $1.62 million orphan disease grant from the Food & Drug Administration.

5 Oct 2014

Open payments database debuts, detailing financial connections between physicians and drug makers

Consumer advocates have pushed for years for this kind of government database in an effort to protect against physicians' conflicts of interest, to safeguard patient care and to prevent unnecessary costs to public health programs.

1 Oct 2014

NIH announces winners of BRAIN Initiative awards

Today the National Institutes of Health (NIH) announced their first round of BRAIN Initiative awards, and six teams from the Massachusetts Institute of Technology (MIT) are among the recipients.

1 Oct 2014

Calling 9-1-1 can speed access to lifesaving treatment, say cardiology researchers

Time is critical for patients experiencing a heart attack, and calling 9-1-1 first will speed access to lifesaving treatment, according to MedStar Heart & Vascular Institute cardiology researchers.

30 Sep 2014

Study: Dietary polyunsaturated fatty acids may reduce coronary heart disease risk

A recent study completed at the University of Eastern Finland shows that dietary polyunsaturated fatty acids may reduce the risk of coronary heart disease. The sources of polyunsaturated fatty acids include fish, vegetable oils, and nuts.

30 Sep 2014

Cardiac arrhythmias pose risk in pulmonary hypertension patients

Supraventricular arrhythmias are common and usually cause clinical deterioration in patients with idiopathic pulmonary arterial hypertension, a study shows.

29 Sep 2014

Galmed Pharmaceuticals purchases EndoPAT devices, accessories from Itamar Medical

Galmed Pharmaceuticals Ltd. ("Galmed"), a clinical-stage biopharmaceutical company focused on the development and commercialization of a once-daily, oral medication for the treatment of liver diseases and cholesterol gallstones, announced today that it purchased 60 EndoPAT™ devices and accessories from Itamar Medical Ltd.

29 Sep 2014

ED more prevalent than previously thought

Specialists in treatment of erectile dysfunction recognize that ED is more prevalent than previously recognized.

29 Sep 2014

Two genes that cause pediatric glaucoma increases risk of future stroke up to ten times

Every year in Canada about 50,000 people suffer from a stroke, caused either by the interruption of blood flow or uncontrolled bleeding in the brain. While many environmental risk factors exist, including high blood pressure and smoking, stroke risk is also frequently inherited. Unfortunately, remarkably little is known regarding stroke's genetic basis.

26 Sep 2014

NCCN ORP awards four research grants to advance development of nintedanib

The National Comprehensive Cancer Network Oncology Research Program has awarded four grants to investigators to evaluate and define the clinical effectiveness of the investigational compound nintedanib (BIBF 1120) in non-small cell lung, colorectal, and gastrointestinal cancers.

25 Sep 2014

MediValve successfully completes post-market clinical evaluation of acWire Guidewire

MediValve, Ltd., a Trendlines portfolio company, today announced that it has successfully completed the first two cases of post-market clinical evaluation of its acWire Guidewire.

24 Sep 2014

Trauma center in Pennsylvania granted Level IV Trauma Center Accreditation status

Level IV Trauma Center Accreditation status has been granted to an additional hospital in Pennsylvania for the period from November 1, 2014 through October 31, 2015.

23 Sep 2014

Vascular News and Research

Leica Microsystems launches new neurosurgical microscope

New miniaturized, wireless monitoring system for heart failure patients

Multi-center study compares clinical performance of AAA procedures in virtual environment

New surface coating for medical devices prevents blood from clotting

BHVH cardiologists implant investigational cardiac pacemaker the size of multivitamin

Neovasc gets conditional IDE approval from FDA to initiate trial for Tiara mitral valve system

MedCure offers Pulsatile Anatomical Trainer service to advance medical research and training

Health Canada approves Lucentis (ranibizumab) for myopic CNV

CTRC researcher receives special $1.62 million orphan disease grant from FDA

Open payments database debuts, detailing financial connections between physicians and drug makers

NIH announces winners of BRAIN Initiative awards

Calling 9-1-1 can speed access to lifesaving treatment, say cardiology researchers

Study: Dietary polyunsaturated fatty acids may reduce coronary heart disease risk

Cardiac arrhythmias pose risk in pulmonary hypertension patients

Galmed Pharmaceuticals purchases EndoPAT devices, accessories from Itamar Medical

ED more prevalent than previously thought

Two genes that cause pediatric glaucoma increases risk of future stroke up to ten times

NCCN ORP awards four research grants to advance development of nintedanib

MediValve successfully completes post-market clinical evaluation of acWire Guidewire

Trauma center in Pennsylvania granted Level IV Trauma Center Accreditation status

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News